APCS and primary systemic amyloidosis: Although no further development of the anti-SAP treatment in systemic amyloidosis is planned, we could speculate that longer-term therapeutic interventions driving active removal of amyloid deposits, particularly in patients with AL amyloidosis, may be beneficial.